18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
11
2019
accepted:
02
01
2020
entrez:
18
1
2020
pubmed:
18
1
2020
medline:
15
4
2020
Statut:
epublish
Résumé
Limbic encephalitis (LE) is an immune-related, sometimes paraneoplastic process of the central nervous system. Initial diagnosis and treatment are based on the clinical presentation as well as antibody profiles and MRI. This study investigated the diagnostic value of integrated 18F-FDG-PET/MRI in the diagnostic work-up of patients with LE for a cerebral and whole-body imaging concept. Twenty patients with suspected LE were enrolled in this prospective study. All patients underwent a dedicated PET/MRI protocol of the brain as well as the whole-body. Two neuroradiologists, one body radiologist and one nuclear medicine physician performed blinded consensus readings of each corresponding MRI and PET/MRI dataset of the brain and whole-body. Diagnostic confidence was evaluated on a Likert scale. Based on integrated PET/MRI 19 / 20 patients were found to show morphologic and / or metabolic changes indicative of LE, whereas sole MRI enabled correct identification in 16 / 20 patients. Three patients with negative MRI showed metabolic changes of the limbic system or extra-limbic regions, shifting the diagnosis from (negative) MRI to positive for LE in PET/MRI. Whole-body staging revealed suspected lesions in 2/20 patients, identified by MRI and PET, one confirmed as malignant and one false positive. Diagnostic confidence for cerebral and whole-body imaging reached higher scores for PET/MRI (cerebral: 2.7 and whole body: 4.8) compared to MRI alone (cerebral: 2.4 and whole body: 4.5). LE diagnosis remains challenging for imaging as it shows only subtle imaging findings in most patients. Nevertheless, based on the simultaneous and combined analysis of morphologic and metabolic data, integrated PET/MRI may enable a dual platform for improved diagnostic confidence and overall detection of LE as well as whole-body imaging for exclusion of paraneoplastic LE.
Identifiants
pubmed: 31951636
doi: 10.1371/journal.pone.0227906
pii: PONE-D-19-32756
pmc: PMC6968877
doi:
Substances chimiques
Contrast Media
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0227906Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Neurol. 2012 Jun;259(6):1106-10
pubmed: 22081102
J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):735-42
pubmed: 25185210
J Neurol. 2013 Nov;260(11):2744-53
pubmed: 23900756
Brain. 2010 Jun;133(Pt 6):1655-67
pubmed: 20511282
Seizure. 2011 Apr;20(3):266-70
pubmed: 21146427
Neurology. 2010 Nov 9;75(19):1735-9
pubmed: 21060097
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):56-65
pubmed: 25223420
PLoS One. 2016 Jun 21;11(6):e0157880
pubmed: 27327617
Ann Neurol. 2005 Oct;58(4):594-604
pubmed: 16178029
Lancet Neurol. 2016 Sep;15(10):1009-10
pubmed: 27571149
Clin Nucl Med. 2010 Jun;35(6):461-3
pubmed: 20479604
Brain. 2005 Aug;128(Pt 8):1764-77
pubmed: 15888538
J Magn Reson Imaging. 2014 Feb;39(2):243-58
pubmed: 24338921
Brain. 2000 Jul;123 ( Pt 7):1481-94
pubmed: 10869059
Neurology. 2010 Dec 14;75(24):2168-75
pubmed: 21172840
J Neuroimaging. 2001 Jan;11(1):55-9
pubmed: 11198529
Epilepsia. 2016 Mar;57(3):475-83
pubmed: 26749370
Ann Neurol. 2009 Jul;66(1):11-8
pubmed: 19670433
Neuroradiology. 2015 Dec;57(12):1203-9
pubmed: 26293130
Arch Neurol. 2004 Nov;61(11):1785-9
pubmed: 15534190
Eur J Neurol. 2013 Dec;20(12):1566-70
pubmed: 23941332
Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):2103-10
pubmed: 19838705
Neurol Neuroimmunol Neuroinflamm. 2017 May 11;4(4):e352
pubmed: 28567435
Pediatr Neurol. 2010 Sep;43(3):217-20
pubmed: 20691947
Epilepsia. 2013 Sep;54(9):1679-87
pubmed: 23889589
Clin Nucl Med. 2012 Sep;37(9):e213-8
pubmed: 22889795
Clin Imaging. 2015 Mar-Apr;39(2):329-33
pubmed: 25487436
Ann Neurol. 2007 Jan;61(1):25-36
pubmed: 17262855
Lancet Neurol. 2010 Jan;9(1):67-76
pubmed: 19962348
Neuroradiology. 2006 Jun;48(6):380-6
pubmed: 16586118
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):353-357
pubmed: 27924371
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
AJNR Am J Neuroradiol. 2014 Mar;35(3):424-31
pubmed: 23413251
J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):681-6
pubmed: 22566598
Ann Nucl Med. 2015 Jun;29(5):420-5
pubmed: 25666569
Invest Radiol. 2014 Dec;49(12):808-15
pubmed: 25010207
Epilepsia. 2011 Dec;52(12):2216-24
pubmed: 22050207
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2328-2337
pubmed: 30056547
AJNR Am J Neuroradiol. 2014 Mar;35(3):418-23
pubmed: 23436051
Indian J Nucl Med. 2018 Apr-Jun;33(2):174-176
pubmed: 29643688
Clin Neuroradiol. 2019 Dec;29(4):623-630
pubmed: 30014154